• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Gut microbiome dysbiosis in the setting of solid organ transplantation: What we have gleaned from human and animal studies.实体器官移植中的肠道微生物群失调:我们从人类和动物研究中所了解到的情况。
World J Transplant. 2022 Jul 18;12(7):157-162. doi: 10.5500/wjt.v12.i7.157.
2
Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation.肠道微生物群落失调与实体器官移植后死亡率升高有关。
Sci Transl Med. 2022 Aug 31;14(660):eabn7566. doi: 10.1126/scitranslmed.abn7566.
3
Solid organ transplantation and gut microbiota: a review of the potential immunomodulatory properties of short-chain fatty acids in graft maintenance.实体器官移植与肠道微生物群:短链脂肪酸在移植物维持中潜在免疫调节特性的综述。
Front Cell Infect Microbiol. 2024 Feb 27;14:1342354. doi: 10.3389/fcimb.2024.1342354. eCollection 2024.
4
Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients.肠道菌群失调的多种指标可预测实体器官移植受者的全因和病因特异性死亡率。
Gut. 2024 Sep 9;73(10):1650-1661. doi: 10.1136/gutjnl-2023-331441.
5
The possible mechanisms of the human microbiome in allergic diseases.人类微生物群在过敏性疾病中的可能机制。
Eur Arch Otorhinolaryngol. 2017 Feb;274(2):617-626. doi: 10.1007/s00405-016-4058-6. Epub 2016 Apr 26.
6
Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.肠道菌群失调是中风和认知障碍的危险因素之一,也是潜在的治疗靶点。
Pharmacol Res. 2021 Feb;164:105277. doi: 10.1016/j.phrs.2020.105277. Epub 2020 Nov 7.
7
[Gut microbiome and renal transplantation].[肠道微生物群与肾移植]
Vnitr Lek. 2023 Winter;69(1):41-46. doi: 10.36290/vnl.2023.006.
8
Gut microbiome in chronic kidney disease: challenges and opportunities.慢性肾脏病中的肠道微生物群:挑战与机遇
Transl Res. 2017 Jan;179:24-37. doi: 10.1016/j.trsl.2016.04.007. Epub 2016 Apr 30.
9
Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.连接免疫系统、系统性慢性炎症和肠道微生物组:性别的作用。
J Autoimmun. 2018 Aug;92:12-34. doi: 10.1016/j.jaut.2018.05.008. Epub 2018 Jun 1.
10
Meta-analysis of alcohol induced gut dysbiosis and the resulting behavioral impact.酒精诱导的肠道菌群失调及其导致的行为影响的荟萃分析。
Behav Brain Res. 2019 Dec 30;376:112196. doi: 10.1016/j.bbr.2019.112196. Epub 2019 Aug 30.

引用本文的文献

1
Individualized Diets in Patients with Kidney Disease and Kidney Transplants: A Narrative Review.肾病及肾移植患者的个体化饮食:一篇叙述性综述
Life (Basel). 2025 May 31;15(6):896. doi: 10.3390/life15060896.
2
Regulation of the immune microenvironment and immunotherapy after liver transplantation.肝移植后免疫微环境的调控与免疫治疗
Front Immunol. 2025 May 12;16:1602877. doi: 10.3389/fimmu.2025.1602877. eCollection 2025.
3
Effect of gut microbiota changes on cytokines IL-10 and IL-17 levels in liver transplantation patients.肠道微生物群变化对肝移植患者细胞因子IL-10和IL-17水平的影响
BMC Infect Dis. 2025 Jan 30;25(1):140. doi: 10.1186/s12879-025-10466-9.
4
Diagnosis and management of inflammatory bowel disease after solid organ transplantation in the era of biologic therapy: a case series.生物治疗时代实体器官移植后炎症性肠病的诊断与管理:病例系列
Front Transplant. 2025 Jan 8;3:1483943. doi: 10.3389/frtra.2024.1483943. eCollection 2024.
5
Blood Microbiota and Its Products: Mechanisms of Interference with Host Cells and Clinical Outcomes.血液微生物群及其产物:干扰宿主细胞的机制与临床结局
Hematol Rep. 2024 Jul 6;16(3):440-453. doi: 10.3390/hematolrep16030043.

本文引用的文献

1
Microbiome is a functional modifier of P450 drug metabolism.微生物群是细胞色素P450药物代谢的功能调节剂。
Curr Pharmacol Rep. 2019 Dec;5(6):481-490. doi: 10.1007/s40495-019-00200-w. Epub 2019 Oct 19.
2
Gut Microbial Metabolites Induce Donor-Specific Tolerance of Kidney Allografts through Induction of T Regulatory Cells by Short-Chain Fatty Acids.肠道微生物代谢产物通过短链脂肪酸诱导调节性 T 细胞诱导供体特异性肾移植耐受。
J Am Soc Nephrol. 2020 Jul;31(7):1445-1461. doi: 10.1681/ASN.2019080852. Epub 2020 Jun 1.
3
Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant.心力衰竭、左心室辅助装置及移植患者的肠道微生物群、内毒素血症、炎症和氧化应激
J Heart Lung Transplant. 2020 Sep;39(9):880-890. doi: 10.1016/j.healun.2020.02.004. Epub 2020 Feb 13.
4
Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients.肾移植受者肠道微生物群的特征与失调
J Clin Med. 2020 Feb 1;9(2):386. doi: 10.3390/jcm9020386.
5
Gut microbiota composition alterations are associated with the onset of diabetes in kidney transplant recipients.肠道微生物组成的改变与肾移植受者糖尿病的发生有关。
PLoS One. 2020 Jan 7;15(1):e0227373. doi: 10.1371/journal.pone.0227373. eCollection 2020.
6
Butyrate-producing gut bacteria and viral infections in kidney transplant recipients: A pilot study.肾移植受者中产生丁酸盐的肠道细菌与病毒感染:一项初步研究。
Transpl Infect Dis. 2019 Dec;21(6):e13180. doi: 10.1111/tid.13180. Epub 2019 Oct 8.
7
Obesity, diabetes, and the gut microbiome: an updated review.肥胖、糖尿病与肠道微生物群:最新综述
Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):3-15. doi: 10.1080/17474124.2019.1543023. Epub 2018 Nov 13.
8
Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites.肠道共生菌将免疫抑制剂他克莫司转化为效力较弱的代谢物。
Drug Metab Dispos. 2019 Mar;47(3):194-202. doi: 10.1124/dmd.118.084772. Epub 2018 Dec 31.
9
The microbiome in autoimmune diseases.自身免疫性疾病中的微生物组。
Clin Exp Immunol. 2019 Jan;195(1):74-85. doi: 10.1111/cei.13158.
10
Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection.抗生素破坏肠道微生物组会加剧急性血管排斥反应。
Transplantation. 2018 Jul;102(7):1085-1095. doi: 10.1097/TP.0000000000002169.

实体器官移植中的肠道微生物群失调:我们从人类和动物研究中所了解到的情况。

Gut microbiome dysbiosis in the setting of solid organ transplantation: What we have gleaned from human and animal studies.

作者信息

Sharma Aparna, Giorgakis Emmanouil

机构信息

Department of Nephrology, University of Arkansas for Medical Sciences, Little Rock, AR 72223, United States.

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72223, United States.

出版信息

World J Transplant. 2022 Jul 18;12(7):157-162. doi: 10.5500/wjt.v12.i7.157.

DOI:10.5500/wjt.v12.i7.157
PMID:36051453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9331413/
Abstract

The human gut microbiome refers to all of the microorganisms present throughout the length of the gastrointestinal tract. Gut flora influence host metabolic and immune processes in myriad ways. They also play an important role in maturation and modulation of the immune system. Dysbiosis or a pathologic alteration in gut flora has been implicated in a number of diseases ranging from metabolic, autoimmune and degenerative. Whether dysbiosis has similar implications in organ transplant has been the focus of a number of pre-clinical and clinical studies. Researchers have observed significant microbiome changes after solid organ transplantation in humans that have been associated with clinical outcomes such as post-transplant urinary tract infections and diarrhea. In this article, we will discuss the available data regarding pathologic alterations in gut microbiome (dysbiosis) in solid organ transplant recipients as well as some of challenges in this field. We will also discuss animal studies focusing on mouse models of transplantation that shed light on the underlying mechanisms that explain these findings.

摘要

人类肠道微生物群是指存在于整个胃肠道中的所有微生物。肠道菌群以多种方式影响宿主的代谢和免疫过程。它们在免疫系统的成熟和调节中也起着重要作用。肠道菌群失调或病理改变与许多疾病有关,包括代谢性、自身免疫性和退行性疾病。肠道菌群失调在器官移植中是否有类似影响一直是许多临床前和临床研究的重点。研究人员观察到,人类实体器官移植后微生物群发生了显著变化,这些变化与移植后尿路感染和腹泻等临床结果有关。在本文中,我们将讨论实体器官移植受者肠道微生物群病理改变(菌群失调)的现有数据,以及该领域的一些挑战。我们还将讨论以移植小鼠模型为重点的动物研究,这些研究揭示了解释这些发现的潜在机制。